TAZ anticorps (AA 174-248)

N° du produit ABIN6148874

Détail du produit anti-TAZ anticorps

Antigène: TAZ (Tafazzin (TAZ))

Épitope: AA 174-248

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp TAZ est non-conjugé

Application: Western Blotting (WB)

Séquence: NDVLPNSPPY FPRFGQKITV LIGKPFSALP VLERLRAENK SAVEMRKALT DFIQEEFQHL KTQAEQLHNH LQPGR

Réactivité croisée: Humain, Souris, Rat

Attributs du produit: Polyclonal Antibodies

Immunogène: Recombinant fusion protein containing a sequence corresponding to amino acids 174-248 of human Tafazzin / TAZ (NP_851830.1).

Isotype: IgG

Information d'application

Indications d'application: WB,1:1000 - 1:2000

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Avoid freeze / thaw cycles.

Détails sur TAZ

Antigène: TAZ (Tafazzin (TAZ))

Autre désignation: TAZ (TAZ Produits)

Synonymes: anticorps wu:fb39f12, anticorps zgc:91803, anticorps MGC54019, anticorps TAZ, anticorps taz, anticorps GB11956, anticorps Afu2g13960, anticorps BTHS, anticorps CMD3A, anticorps EFE, anticorps EFE2, anticorps G4.5, anticorps LVNCX, anticorps Taz1, anticorps 5031411C02Rik, anticorps 9130012G04Rik, anticorps AW107266, anticorps AW552613, anticorps tafazzin, anticorps tafazzin L homeolog, anticorps tafazzin homolog, anticorps TAZ, anticorps taz, anticorps taz.L, anticorps LOC550948, anticorps AFUA_2G13960, anticorps AOR_1_318014, anticorps Tsp_06712, anticorps Taz

Sujet: This gene encodes a protein that is expressed at high levels in cardiac and skeletal muscle. Mutations in this gene have been associated with a number of clinical disorders including Barth syndrome, dilated cardiomyopathy (DCM), hypertrophic DCM, endocardial fibroelastosis, and left ventricular noncompaction (LVNC). Multiple transcript variants encoding different isoforms have been described. A long form and a short form of each of these isoforms is produced, the short form lacks a hydrophobic leader sequence and may exist as a cytoplasmic protein rather than being membrane-bound. Other alternatively spliced transcripts have been described but the full-length nature of all these transcripts is not known.,TAZ,BTHS,CMD3A,EFE,EFE2,G4.5,LVNCX,Taz1,tafazzin,Cancer,Signal Transduction,Endocrine & Metabolism,Lipid Metabolism,TAZ

Poids moléculaire: 25 kDa/27 kDa/28 kDa/29 kDa/30 kDa/31 kDa/33 kDa

ID gène: 6901

UniProt: Q16635